Advertisement

The Drug-Carrier Potential of Liposomes in Cancer Chemotherapy

  • Gregory Gregoriadis

Abstract

The treatment of cancer is associated with a variety of problems which, to various extents, contribute to the failure of most therapeutic attempts. The outstanding cause of our present difficulties in treating cancer derives from the absence of specificity in the action of available antitumour drugs which in most cases will kill malignant and normal cells alike. Because of this lack of discrimination, a variety of side effects can harass or even threaten the life of treated patients.

Keywords

Lysosomal Storage Disease Therapeutic Attempt Antitumour Drug Liposomal Carrier Endocytic Vacuole 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bangham, A.D., Hill, M.W. and Miller, N.G.A. (1974) in “Methods in Membrane Biology” (E.D. Korn, ed.) p.1, vol. 1, Plenum PressGoogle Scholar
  2. 2.
    Segal, A.W., Wills, E.J., Richmond, J.E., Slavin, G., Black, C.D.V. and Gregoriadis, G. (1974) Br. J. Exp. Pathol. 55, 320PubMedGoogle Scholar
  3. 3.
    Gregoriadis, G. (1974) in “Enzyme Therapy in Lysosomal Storage Diseases” (J.M. Tager, G.J.M. Hooghwinkel and W.Th. Daems, eds.) p.131, North-Holland Publishing Company, Amsterdam.Google Scholar
  4. 4.
    Gregoriadis, G. and Ryman, B.E. (1972) Biochem. J. 129, 123PubMedGoogle Scholar
  5. 5.
    Gregoriadis, G., Putman, D., Louis, L. and Neerunjun, E.D. (1974) Biochem. J. 140, 323PubMedGoogle Scholar
  6. 6.
    Rahman, V.-E. and Wright, B.J. (1975) J. Cell Biol. 65, 112PubMedCrossRefGoogle Scholar
  7. 7.
    Juliano, R.L. and Stamp, D. (1975) Biochem. Biophys. Res. Comm. 63, 651PubMedCrossRefGoogle Scholar
  8. 8.
    McDougall, I.R., Dunnick, J.K., McNamee, M.G. and Kriss, J.P. (1974) Proc. Nat. Acad. Sci. U.S.A. 71, 3487CrossRefGoogle Scholar
  9. 9.
    Gregoriadis, G. and Neerunjun, E.D. (1974) Eur. J. Biochem.Google Scholar
  10. 10.
    Gregoriadis, G. and Buckland, R.A. (1973) Nature 244, 170PubMedCrossRefGoogle Scholar
  11. 11.
    Papahadjopoulos, D., Mayhew, E., Poste, G. and Smith, S. (1974) Nature 252, 163PubMedCrossRefGoogle Scholar
  12. 12.
    Magee, W.E., Goff, C.W., Schoknecht, J., Smith, M.D. and Cherian, K. (1974) J. Cell Biol. 63, 492PubMedCrossRefGoogle Scholar
  13. 13.
    Black, C.D.V. and Gregoriadis, G. (1974) Biochem. Soc. Trans. 2, 869Google Scholar
  14. 14.
    Gregoriadis, G. and Neerunjun, E.D. (1975) Res. Comm. Chem. Pathol. Pharm. 10, 351Google Scholar
  15. 15.
    Gregoriadis, G. (1973) FEBS Lett. 36, 292PubMedCrossRefGoogle Scholar
  16. 16.
    Colley, C.M. and Ryman, B.E. (l975) Biochem. Soc. Trans. 3,157Google Scholar
  17. 17.
    Gregoriadis, G. (1973) Biochem. Soc. Trans. 2, 117Google Scholar
  18. 18.
    Gregoriadis, G. and Neerunjun, E.D. (1975) Biochem. Biophys. Res. Comm. In pressGoogle Scholar
  19. 19.
    Gregoriadis, G., Swain, C.P., Wills, E.J. and Tavill, A.S. (1974) Lancet i, 1313CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • Gregory Gregoriadis
    • 1
  1. 1.Clinical Research CentreHarrowUK

Personalised recommendations